ReviewPakistan journal of medical sciences2025
Impact of dialysis modality on survival after kidney transplant failure: A systematic review and meta-analysis.
Review in Pakistan journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: We reviewed evidence on survival of dialysis after graft failure (DAGF) patients based on the selected dialysis modality (peritoneal dialysis [PD] vs hemodialysis[HD]). Methods: PubMed, CENTRAL, Embase, Scopus, and Web of Science were searched for all type of studies comparing PD with HD in DAGF patients and reporting survival rates, technique survival or complications. The last date of the search was May 5, 2024. The Newcastle-Ottawa Scale was used to assess study quality. We extracted both crude and multivariable-adjusted data from the studies for the meta-analysis which were pooled as odds ratio (OR) and Hazard ratios (HR) respectively. Outcomes were assessed at the longest follow-up of the included studies. Results: Seven studies were included comparing 2494 patients on PD and 4041 patients on HD. Meta-analysis of crude data showed that mortality rates did not differ between PD and HD in patients receiving DAGF (OR: 0.98 95% CI: 0.76, 1.27 I Conclusions: Very-:low quality evidence mostly from retrospective studies shows that dialysis modality may not impact survival rates in patients returning to DAGF. There is a need for robust randomized controlled trials with large sample sizes to provide better evidence.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.